Dr. Hönle AG (HNL) — Cash Flow Reinvestment Rate
Latest as of June 2026:
0.12x
Dr. Hönle AG (HNL) has a Cash Flow Reinvestment Rate of 0.12x as of June 2026, reinvesting €266.00K (capex €266.00K ) from operating cash flow of €2.20 Million. See cash generation quality of Dr. Hönle AG to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.12x
(Capex + Investments) / Operating CF
Total Reinvested
€266.00K
Capex + Investments
Operating Cash Flow
€2.20 Million
EUR
Capital Expenditures
€266.00K
EUR
Dr. Hönle AG Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Dr. Hönle AG across 11 annual periods. For the full cash flow conversion analysis, see Dr. Hönle AG (HNL) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Dr. Hönle AG (2014–2025)
Year-by-year capital reinvestment analysis for Dr. Hönle AG. See HNL FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | €2.04 Million | €4.99 Million | €1.90 Million | ▼ -2.0% |
| 2024 | 0.42x | €2.31 Million | €5.53 Million | €2.09 Million | ▼ -76.5% |
| 2023 | 1.78x | €5.58 Million | €3.14 Million | €2.93 Million | ▼ -88.3% |
| 2021 | 15.12x | €17.09 Million | €1.13 Million | €17.09 Million | ▲ +259.9% |
| 2020 | 4.20x | €30.40 Million | €7.23 Million | €30.20 Million | ▲ +265.1% |
| 2019 | 1.15x | €19.48 Million | €16.92 Million | €19.28 Million | ▲ +158.6% |
| 2018 | 0.44x | €10.78 Million | €24.22 Million | €10.58 Million | ▼ -47.3% |
| 2017 | 0.85x | €5.56 Million | €6.58 Million | €5.36 Million | ▼ -23.4% |
| 2016 | 1.10x | €9.53 Million | €8.63 Million | €4.98 Million | ▲ +364.9% |
| 2015 | 0.24x | €2.17 Million | €9.16 Million | €2.14 Million | ▼ -43.4% |
| 2014 | 0.42x | €3.14 Million | €7.49 Million | €3.08 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow